News
Academy
Publications
Media
Conferences
Columns
Resources
Events
Subscribe
Event Calendar

|Articles|July 30, 2012

Adoption of Central IRBs

Author(s)Reid Paul

Video slideshow interview of Cynthia Hahn research compliance officer at Feinstein Institute for medical research

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

© putilov_denis - © putilov_denis - stock.adobe.com

Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection

ByLauren Crooks, MSc, Greta Marie van Schoor, PhD, Anthony Everhart, MD, Bill Byrom, PhD, and Thijs Sondag

July 31st 2026

How to Prevent Continuous Data Review from Just Shifting the Manual Burden

ByRaviv Pryluk, PhD,Andy Studna, Senior Editor

July 31st 2026

ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access

ByAndy Studna, Senior Editor

July 31st 2026

© Grispb - © Grispb - stock.adobe.com

Artificial Intelligence in Clinical Trials: From Pilots to Practice

ByAndy Studna, Senior Editor

July 30th 2026

What the Industry Needs to Get Right for Real-Time Data Review to Scale

ByRaviv Pryluk, PhD,Andy Studna, Senior Editor

July 30th 2026

Trending on Applied Clinical Trials Online

ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access

Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection

ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion

FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility

ACT Brief: Data Pipeline Standardization for Real-Time Analysis, Sponsor Accountability Beyond Contracts, and Autoimmune Pipeline Expansion